Chinese University of Hong Kong clinical trial pipeline

19 trials changed in the last 30 days: 0 stopped, 10 with notable changes, 9 with minor changes only.

1. Notable

   RADAR · Hemiarch Replacement and Hemiarch Plus Stent Implantation…RADAR · Hemiarch Replacement and Hemiarch Plus Stent Implantation in Acute Aortic Dissection

   Primary completion pushed from Sep 30, 2026 to Sep 30, 2027

   Also in this update: Completion pushed from Sep 30, 2027 to Sep 30, 2028

   Chinese University of Hong Kong·Not applicable· NCT06044259· Registry history of NCT06044259 on ClinicalTrials.gov (opens the registry)

   Updated Sep 30, 2026

2. Notable

   M3-AA · Diagnostic Accuracy of M3 in Predicting Colorectal…M3-AA · Diagnostic Accuracy of M3 in Predicting Colorectal Advanced Adenoma Recurrence (M3-AA)

   Primary completion pushed from Dec 15, 2024 to Dec 31, 2028

   Also in this update: Trial status changed: Unknown → Recruiting; Completion pushed from Jun 15, 2025 to Dec 31, 2028

   Chinese University of Hong Kong·Not specified· NCT05144152· Registry history of NCT05144152 on ClinicalTrials.gov (opens the registry)

   Updated Sep 22, 2026

3. Notable

   GIMA · Prediction of Gastric Cancer in Intestinal Metaplasia and…GIMA · Prediction of Gastric Cancer in Intestinal Metaplasia and Atrophic Gastritis

   Primary completion pushed from Dec 1, 2025 to Dec 1, 2026

   Also in this update: Trial status changed: Unknown → Recruiting; Completion pushed from Dec 31, 2025 to Dec 31, 2026

   Chinese University of Hong Kong·Not specified· NCT04840056· Registry history of NCT04840056 on ClinicalTrials.gov (opens the registry)

   Updated Sep 22, 2026

4. Notable

   Helicobacter Pylori, Atrophic Gastritis and Intestinal Metaplasia…Helicobacter Pylori, Atrophic Gastritis and Intestinal Metaplasia Registry and Prospective Study

   Primary completion pushed from Dec 1, 2025 to Dec 31, 2030

   Also in this update: Trial status changed: Unknown → Recruiting; Completion pushed from Dec 31, 2025 to Dec 31, 2030

   Chinese University of Hong Kong·Not specified· NCT05053945· Registry history of NCT05053945 on ClinicalTrials.gov (opens the registry)

   Updated Sep 22, 2026

5. Notable

   Fezolinetant for Vasomotor Symptoms in Men Receiving Androgen…Fezolinetant for Vasomotor Symptoms in Men Receiving Androgen Deprivation Therapy (ADT)

   Recruitment opened

   Chinese University of Hong Kong·Phase 2· NCT07568236· Registry history of NCT07568236 on ClinicalTrials.gov (opens the registry)

   Updated Oct 7, 2026

6. Notable

   Mindfulness-based Intervention for Hotel Staff

   Recruitment opened

   Chinese University of Hong Kong·Not applicable· NCT07541027· Registry history of NCT07541027 on ClinicalTrials.gov (opens the registry)

   Updated Sep 25, 2026

7. Notable

   DREAM-1 · Duodenal pulsENDO as an Early Treatment for Type 2 DM

   Recruitment opened

   Chinese University of Hong Kong·Not applicable· NCT07376486· Registry history of NCT07376486 on ClinicalTrials.gov (opens the registry)

   Updated Sep 15, 2026

8. Notable

   DRESS-1 · Duodenal pulsENDO for Suboptimally Controlled Type II…DRESS-1 · Duodenal pulsENDO for Suboptimally Controlled Type II Diabetes Mellitus and Steatotic Liver Disease

   Recruitment opened

   Chinese University of Hong Kong·Not applicable· NCT07390422· Registry history of NCT07390422 on ClinicalTrials.gov (opens the registry)

   Updated Sep 15, 2026

9. Notable

   DJBS-OMS · Duodenal-jejunal Bypass Sleeve (DJBS) for Obesity and…DJBS-OMS · Duodenal-jejunal Bypass Sleeve (DJBS) for Obesity and Metabolic Syndrome

   Recruitment opened

   Chinese University of Hong Kong·Not applicable· NCT07675122· Registry history of NCT07675122 on ClinicalTrials.gov (opens the registry)

   Updated Sep 15, 2026

10. Notable

    Risk Assessment and Management Program (RAMP) on Knee…Risk Assessment and Management Program (RAMP) on Knee Osteoarthritis in Primary Care

    Primary completion date changed from estimate of Nov 30, 2025 to May 30, 2026

    Also in this update: Trial status changed: Unknown → Completed

    Chinese University of Hong Kong·Not applicable· NCT06283147· Registry history of NCT06283147 on ClinicalTrials.gov (opens the registry)

    Updated Oct 2, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.